Last update :
29/10/2024
Anticancer drug   Daunorubicin/cytarabine liposomale  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Vyxeos France, Germany, Great Britain, United States of America
Route of administration   Route of administration :Daunorubicin/cytarabine liposomale     
Route
Intravenous infusion

  Mentions Légales